1114 related articles for article (PubMed ID: 16631243)
41. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
42. [Management of gestational trophoblastic disease].
Noal S; Joly F; Leblanc E
Gynecol Obstet Fertil; 2010 Mar; 38(3):193-8. PubMed ID: 20189434
[TBL] [Abstract][Full Text] [Related]
43. Human chorionic gonadotropin and associated molecules.
Cole LA
Expert Rev Mol Diagn; 2009 Jan; 9(1):51-73. PubMed ID: 19099349
[TBL] [Abstract][Full Text] [Related]
44. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
45. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
46. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies.
Fisher RA; Savage PM; MacDermott C; Hook J; Sebire NJ; Lindsay I; Seckl MJ
Gynecol Oncol; 2007 Dec; 107(3):413-9. PubMed ID: 17942145
[TBL] [Abstract][Full Text] [Related]
47. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
Lertkhachonsuk R; Limpongsanurak S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
[TBL] [Abstract][Full Text] [Related]
48. [Value of hysteroscopy and laparoscopy in differential diagnosis of gestational trophoblastic neoplasia].
Feng FZ; Xiang Y; He HJ; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):464-7. PubMed ID: 17961336
[TBL] [Abstract][Full Text] [Related]
49. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
50. [Persistent low hCG levels beyond pregnancy: report of two cases and review of the literature].
De Backer B; Goffin F; Nisolle M; Minon JM
Ann Biol Clin (Paris); 2013; 71(4):496-502. PubMed ID: 23906583
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
[TBL] [Abstract][Full Text] [Related]
52. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
Cole LA; Kohorn EI
J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
[TBL] [Abstract][Full Text] [Related]
53. [Clinical characteristics and management of gestational trophoblastic disease in women aged 50 years or more].
Feng FZ; Xiang Y; Wan XR; Yin SJ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):605-8. PubMed ID: 16202316
[TBL] [Abstract][Full Text] [Related]
54. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.
Feltmate CM; Genest DR; Wise L; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 2001 Sep; 82(3):415-9. PubMed ID: 11520134
[TBL] [Abstract][Full Text] [Related]
55. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
56. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
[TBL] [Abstract][Full Text] [Related]
57. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
58. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
[TBL] [Abstract][Full Text] [Related]
60. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
Lurain JR
Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
